These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30539019)

  • 1. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
    Hu G; Liu Q; Ma JY; Liu CY
    Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
    Tian C; Song W; Tian X; Sun Y
    Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
    Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
    Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
    BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
    Ma JY; Ke LC; Liu Q
    Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
    Tan D; Fu Y; Su Q; Wang H
    Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
    Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
    Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: A meta-analysis involving 2099 patients.
    Han SN; Feng SJ; Liu Y
    Kaohsiung J Med Sci; 2021 Jan; 37(1):55-62. PubMed ID: 32783332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
    Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
    Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.
    Song W; Tian C; Wang K; Zhang RJ; Zou SB
    PLoS One; 2017; 12(6):e0178762. PubMed ID: 28575033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
    Li W; Tao L; Lu M; Xiu D
    Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
    Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
    Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
    Zhou LH; Luo XF
    Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xu H; He A; Liu A; Tong W; Cao D
    Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
    Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
    Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
    Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
    World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
    Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
    Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.